Clinical Trial News and Research

RSS

Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award

Novartis announced the winners of the 2018 eXcellence in Ophthalmology Vision Award for nonprofit eye health initiatives at EURETINA 2018.

25 Sep 2018

Diets rich in carbohydrates reduce body weight and fat

Diets high in carbohydrates reduce body weight and body fat and improve insulin function in overweight individuals, according to a new study published in Nutrients.

25 Sep 2018

Study: Women with non-small cell lung cancers live longer than their male counterparts

Women diagnosed with non-small cell lung cancers live longer than their male counterparts, according to results of a SWOG study presented today by Kathy Albain, MD, the Huizenga Family Endowed Chair in Oncology Research at Loyola University Chicago Stritch School of Medicine, at the International Association for the Study of Lung Cancer's 19th World Conference on Lung Cancer in Toronto, Ontario, Canada.

25 Sep 2018

Clinical trial investigators found non-compliant with requirement to report results on EU register

According to EU legislation, clinical trials must be prospectively registered in the European Union Clinical Trials Register and the main results must be reported there one year after completion of the trial. This information is thus publicly available.

25 Sep 2018

Your Vision Matters: How to Protect Your Eyesight

Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.

24 Sep 2018

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Epizyme, Inc., a clinical-stage company developing novel epigenetic therapies, today announced the U.S. Food and Drug Administration has lifted the partial clinical hold that had paused U.S.-based enrollment of new patients in its tazemetostat clinical trials.

24 Sep 2018

Views of minority women on gender, race/ethnicity may affect how they seek help for health needs

Black women are more likely to be diagnosed at later stages of breast cancer partly due to barriers to timely screening mammography.

24 Sep 2018

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.

24 Sep 2018

Study: Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation

A multicenter clinical trial has found that a minimally invasive procedure called transcatheter mitral valve repair significantly reduced hospitalizations and mortality for heart failure patients with moderate-to-severe or severe functional mitral regurgitation.

24 Sep 2018

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus-related head and neck cancer.

24 Sep 2018

New research suggests power of zebrafish as tool for cancer drug discovery

The lab of Leonard Zon, MD, at Boston Children's Hospital has long been interested in making blood stem cells in quantity for therapeutic purposes.

24 Sep 2018

Transcatheter mitral-valve repair in patients with heart failure

A new heart device called the MitraClip (from Abbott) has been shown to benefit patients with heart failure and reduce death rates among them significantly.

23 Sep 2018

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

Combating glioblastoma remains a major challenge due the complex nature of these tumors, the inability of drugs to penetrate the brain tissue, and lack of correlation between animal models and the human condition.

21 Sep 2018

$CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL$

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

AbbVie, a research-based global biopharmaceutical company, announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion for VENCLYXTO® in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia who have received at least one prior therapy.

21 Sep 2018

New clinical trial evaluates aesthetic results of conservative surgery in breast cancer

Belén Merck Navarro, Medicine professor at Valencia and Castellón's CEU UCH university is the only Spaniard among the 17 surgeons from 11 different countries that specialize in breast cancer who took part in a clinical trial on the usefulness of 3D images to evaluate the aesthetic results of conservative surgery in breast cancer

21 Sep 2018

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.

21 Sep 2018

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

A clinical trial testing infusions of combination antibodies in people living with HIV has begun at the National Institutes of Health.

20 Sep 2018

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Sesen Bio, Inc., a late-stage clinical company developing fusion protein therapies for the treatment of cancer, today announced that the company will present its three-month Phase 3 VISTA Trial data during a poster session at the Global Congress on Bladder Cancer 2018.

20 Sep 2018

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase 3 trials in a few months.

20 Sep 2018

Manx Telecom unveils MT clearSound that improves clarity of mobile phone calls

Manx Telecom is delighted to announce the launch today on the Isle of Man of MT clearSound, a new, personal mobile phone product which dramatically improves the clarity of mobile phone calls. The product is available at no additional cost to PayMonthly customers on the Manx Telecom network.

20 Sep 2018

Clinical Trial News and Research

Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award

Diets rich in carbohydrates reduce body weight and fat

Study: Women with non-small cell lung cancers live longer than their male counterparts

Clinical trial investigators found non-compliant with requirement to report results on EU register

Your Vision Matters: How to Protect Your Eyesight

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Views of minority women on gender, race/ethnicity may affect how they seek help for health needs

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Study: Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation

New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer

New research suggests power of zebrafish as tool for cancer drug discovery

Transcatheter mitral-valve repair in patients with heart failure

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

CHMP grants positive opinion for VENCLYXTO plus rituximab for treating relapsed/refractory CLL

New clinical trial evaluates aesthetic results of conservative surgery in breast cancer

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Manx Telecom unveils MT clearSound that improves clarity of mobile phone calls

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer